Correlation Between Catalyst Pharmaceuticals and Mind Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Mind Medicine, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Mind Medicine.

Diversification Opportunities for Catalyst Pharmaceuticals and Mind Medicine

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Catalyst and Mind is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Mind Medicine go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Mind Medicine

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to under-perform the Mind Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Catalyst Pharmaceuticals is 2.87 times less risky than Mind Medicine. The stock trades about -0.06 of its potential returns per unit of risk. The Mind Medicine is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  665.00  in Mind Medicine on August 28, 2024 and sell it today you would earn a total of  96.00  from holding Mind Medicine or generate 14.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Mind Medicine

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Mind Medicine 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mind Medicine are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Mind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Catalyst Pharmaceuticals and Mind Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Mind Medicine

The main advantage of trading using opposite Catalyst Pharmaceuticals and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.
The idea behind Catalyst Pharmaceuticals and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm